Filing Details
- Accession Number:
- 0001209191-20-054118
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-07 16:11:31
- Reporting Period:
- 2020-10-05
- Accepted Time:
- 2020-10-07 16:11:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643921 | N. Sangeeta Bhatia | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-05 | 8,729 | $126.68 | 14,424 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-10-05 | 291 | $262.66 | 14,133 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-05 | 594 | $263.54 | 13,539 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-05 | 892 | $264.60 | 12,647 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-05 | 1,787 | $265.82 | 10,860 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-05 | 2,070 | $266.66 | 8,790 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-05 | 2,670 | $267.92 | 6,120 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-05 | 2,212 | $268.61 | 3,908 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-10-05 | 8,729 | $0.00 | 8,729 | $126.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-06-03 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $262.66 (range $262.10 to $263.06).
- Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $263.54 (range $263.12 to $264.01).
- Open market sales reported on this line occurred at a weighted average price of $264.60 (range $264.18 to $264.92).
- Open market sales reported on this line occurred at a weighted average price of $265.82 (range $265.25 to $266.19).
- Open market sales reported on this line occurred at a weighted average price of $266.66 (range $266.27 to $267.16).
- Open market sales reported on this line occurred at a weighted average price of $267.92 (range $267.39 to $268.35).
- Open market sales reported on this line occurred at a weighted average price of $268.61 (range $268.39 to $269.00).
- Fully vested.
Billionaire Hedge Funds
